Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

Researchers have found in a new study that semaglutide could provide cardiovascular benefits to high-risk patients even ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests. The drug, ...

Experts say the right diet may offer the same effects as Ozempic by curbing hunger and promoting steady weight loss.

New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience ...

Separate study finds GLP-1 medicines combined with bariatric surgery may significantly reduce risk of serious cardiovascular ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed pounds, data suggests. The drug, which contains the active ingredient semaglutide, works by reducing food cravings ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed pounds, data suggests. The drug, which contains the active ingredient semaglutide, works by reducing food ...